Dr. Javier G Quintero-chica, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 19 E Market St, Rhinebeck, NY 12572 Phone: 845-876-2433 |
Maria Gibbons, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6805 Route 9, Suite 27, Rhinebeck, NY 12572 Phone: 845-876-2222 Fax: 845-876-2045 |
Dr. Michael Christopher Madigan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6805 Route 9, Ste 27, Rhinebeck, NY 12572 Phone: 845-876-2222 |
Q Optical Optometrist Medicare: Medicare Enrolled Practice Location: 12 Garden St, Rhinebeck, NY 12572 Phone: 845-876-2433 |
Rhinebeck Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 6805 Route 9, Suite 27, Rhinebeck, NY 12572 Phone: 845-876-2222 Fax: 845-876-2045 |
News Archive
The WIN Consortium, supported by its media partner Nature Publishing Group, has opened registration for the second annual WIN Symposium, to be held in the Palais des Congrès, Paris, on the 7th to 9th of July 2010. The WIN Symposium is an open and interactive forum designed to promote rapid translation of ground-breaking personalized cancer medicine discoveries to clinical practice.
SynerMed, Inc., the largest Medicaid managed service organization in the country, today announced the achievement of "Elite" status on the 2010 Standards of Excellence assessment administered by the California Association of Physician Groups, the nation's largest professional association representing physicians practicing in the managed care model.
Scientists have discovered that an amino acid called asparagine is essential for breast cancer spread, and by restricting it, cancer cells stopped invading other parts of the body in mice, according to research part-funded by Cancer Research UK and published in the journal Nature today, (Wednesday).
DPI effectively switches off the cancer stem cells, preventing their proliferation. "It's extraordinary; the cells just sit there as if in a state of suspended animation" explains Professor Michael Lisanti, Chair of Translational Medicine and lead investigator.
CoLucid Pharmaceuticals, Inc., and ILDONG Pharmaceutical Co., Ltd., announced today that they have entered into a distribution and supply agreement for Lasmiditan in South Korea and Southeast Asia.
› Verified 1 days ago